Cargando…
Herceptin responsive lung adenocarcinoma in the setting of bilateral synchronous lung primaries and breast carcinoma
The incidence of human epidermal growth factor receptor 2 (Her-2) mutations in lung adenocarcinoma is approximately 3%; however, its significance in the management of these lung cancers remains under investigation. We describe an incidental but unique opportunity to evaluate the response to treatmen...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264176/ https://www.ncbi.nlm.nih.gov/pubmed/28197225 http://dx.doi.org/10.4103/1817-1737.182901 |